Key points A 47-year-old French-speaking woman of African descent presented to the emergency department with a 1-week history of severe foot pain and difficulty walking. For the preceding 2 months she ...

Low-dose corticosteroids (such as dexamethasone, 0.125-0.5 mg q.h.s ... Intralesional corticosteroids (such as triamcinolone acetonide, 2.5-10 mg/cc) are frequently effective in treating inflamed ...

Failure to suppress cortisol levels below 50 nmol/l after low dose dexamethasone (0.5 mg every 6 h for eight doses ending at 0300 h, or 1 mg at 2300 h with serum cortisol measured the following ...

For decades, the diagnosis of multiple myeloma required evidence of end-organ damage characterized by myeloma-defining events ...

CMS’s merit based incentive payment system (MIPS) has evolved, requiring ophthalmology practices to keep pace to avoid penalties.

For patients with inadequately controlled type 2 diabetes receiving dulaglutide, switching to tirzepatide is associated with additional hemoglobin A1c (HbA1c) reduction and weight loss compared with ...

Mexiletine appears to be safe and is likely an effective treatment for managing symptoms of myotonia (delayed muscle relaxation after a contraction) in people wit ...

Nintendo has also given the console hardware a much-needed upgrade. The Switch 2 has a larger 7.9-inch display compared to the original Switch’s 6.2-inch screen, and the Joy-Con controllers now ...

It’s been more than eight years since the original Nintendo Switch launched in March 2017, and now we have the full lowdown on what’s next: the Nintendo Switch 2. In a big Nintendo Direct at ...

The Nintendo Switch 2 is real and it's launching in June! After literal years of unverified rumors, dubious leaks and copious amounts of online speculation, Nintendo has lifted the lid on its next ...

After seven years on the market, 150 million systems, and more than 1 billion games sold for the original Switch, Nintendo is finally ushering in its next console--the Nintendo Switch 2.